Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30-49 Years: The population-based registry in the province of Turin, Italy (original) (raw)
Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years
M. Trovati
Diabetes Care, 1999
View PDFchevron_right
Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain
Joan Verdaguer
Diabetes/Metabolism Research and Reviews, 2013
View PDFchevron_right
Clinical phenotype and -cell autoimmunity in Italian patients with adult-onset diabetes
P. Travaglini
European Journal of Endocrinology, 2006
View PDFchevron_right
Type 1 diabetes in insulin-treated adult-onset diabetic subjects
Ian Mackay
Diabetes Research and Clinical Practice, 1998
View PDFchevron_right
Latent autoimmune diabetes in adults in a population-based cohort of Polish patients with newly diagnosed diabetes mellitus
Maria Gorska
Archives of Medical Science, 2012
View PDFchevron_right
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15?34 yrs) in the Diabetes Incidence Study in Sweden (DISS)
Lennarth Nyström
Diabetologia, 2003
View PDFchevron_right
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes
J. Schepper, H. Dorchy, L. Van Gaal
Diabetologia, 2006
View PDFchevron_right
Correlation between the prevalence of type 1 diabetes with the daily insulin dose and the autoimmune process against glutamic acid decarboxylase in adults
M. Tronko
European Journal of Internal Medicine, 2009
View PDFchevron_right
A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years
Luis Monge
Diabetic Medicine, 2004
View PDFchevron_right
The Number of Markers of Pancreatic Autoimmunity Is Proportional to the Risk for Type 1 Diabetes Mellitus in Italian and English Patients with Organ-Specific Autoimmune Diseases
Renato Zanchetta
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Gender differences in GAD antibody– positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases
Bengt Hallengren
Diabetes/Metabolism Research and Reviews, 2004
View PDFchevron_right
Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study
R. Buzzetti
Metabolism, 1998
View PDFchevron_right
Residual -Cell Function and Male/Female Ratio Are Higher in Incident Young Adults Than in Children: The registry of type 1 diabetes of the province of Turin, Italy, 1984-2000
Cristina Runzo, S. Pinach
Diabetes Care, 2005
View PDFchevron_right
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry
Leonard Kaufman
Diabetes Care, 2000
View PDFchevron_right
The prevalence of latent autoimmune diabetes in adults and its correlates in patients with type 2 diabetes in Kerman, Iran [2011
Mohammadhossein Gozashti
View PDFchevron_right
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013;36:908-913
Sinead Brophy
Diabetes Care, 2014
View PDFchevron_right
Adult-Onset Atypical (Type 1) Diabetes: Additional insights and differences with type 1A diabetes in a European Mediterranean population
Josep Oriola
Diabetes Care, 2004
View PDFchevron_right
Role of anti-GAD, anti-IA2 antibodies and C-peptide in differentiating latent autoimmune diabetes in adults from type 2 diabetes mellitus
Sujesh Kumar
International Journal of Diabetes in Developing Countries, 2015
View PDFchevron_right
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes
Jan Bolinder
Diabetes Care, 1999
View PDFchevron_right
Latent Autoimmune Diabetes of Adults Is Phenotypically Similar to Type 1 Diabetes in a Minority Population
Kristina Djekic
The Journal of Clinical Endocrinology & Metabolism, 2012
View PDFchevron_right
Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): Absence of rapid beta-cell loss in patients with tight metabolic control
L. Chaillous
Diabetes & Metabolism, 2010
View PDFchevron_right
Clinical and Genetic Heterogeneity of Latent Autoimmune Diabetes in Adults: Response to Fukui et al
Pal Panczel, Nora Hosszufalusi
Diabetes Care, 2003
View PDFchevron_right
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Edwin Gale
Diabetologia, 2006
View PDFchevron_right
High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry
Luc Van Gaal
Diabetes Care, 2000
View PDFchevron_right
The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus
Hüsrev Hatemi
Journal of Diabetes and its Complications, 2005
View PDFchevron_right
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
Jan Bolinder
Diabetes/Metabolism Research and Reviews, 2000
View PDFchevron_right